| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Khan Najat | Chief R&D Commercial Officer, Director | 41 S. RIO GRANDE STREET, SALT LAKE CITY | /s/ Kyle Nelson, attorney-in-fact | 19 Aug 2025 | 0002020969 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | RXRX | Class A Common Stock | Tax liability | $21,370 | -3,789 | -0.53% | $5.64 | 704,796 | 15 Aug 2025 | Direct | F1 |
| transaction | RXRX | Class A Common Stock | Sale | $202,173 | -36,599 | -5.2% | $5.52 | 668,197 | 18 Aug 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units. |
| F2 | Represents shares that have been required to be sold by the Issuer to satisfy the tax withholding and remittance obligations in connection with the vesting of restricted stock units. |